Optum Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Optum Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011344
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Optum Inc (Optum), a subsidiary of UnitedHealth Group Inc is a healthcare service provider that offers health IT, pharmacy care services, population health management, data and analytics, financial services, health care delivery, revenue cycle management, and health plan operations. The company also offers operations and administration for health plan market, identification of markets; navigate regulation, and other services. Optum caters to physicians, hospitals and care organizations, employers, health plan organizations, life sciences companies and government organizations. The company has its presence in Overland Park, Louisville, Milwaukee, Providence, Reston, Rocky Hill, Salt Lake City and San Francisco, among others. Optum is headquartered in Eden Prairie, Minnesota, the US.

Optum Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Optum Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Optum Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Optum Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Optum Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Optum Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Optum Inc, Medical Equipment, Deal Details 10
Venture Financing 10
MedSynergies Raises US$65 Million In Venture Financing 10
MedSynergies Secures US$25.05 Million In Financing Round 11
Partnerships 12
OptumCare Enters into Agreement with Allscripts Healthcare 12
MedSynergies Forms Joint Venture with Sentara Healthcare 13
MedSynergies Forms Joint Venture with Catholic Health 14
MedSynergies Forms Joint Venture with Excellence Headquarters 15
MedSynergies Forms Joint Venture with Vanguard Health 16
Acquisition 17
Optum to Acquire Surgical Care Affiliates 17
Optum to Acquire MedSynergies, Healthcare IT Company 19
Optum Inc – Key Competitors 20
Optum Inc – Key Employees 21
Optum Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Corporate Communications 23
Mar 17, 2016: UnitedHealthcare and Optum Support People Affected by Floods in Mississippi 23
Mar 17, 2016: UnitedHealthcare and Optum Support People Affected by Floods in Texas 24
Mar 11, 2016: UnitedHealthcare and Optum Support People Affected by Floods in Louisiana 25
Other Significant Developments 26
Nov 29, 2017: AMGA, Optum Announce Collaborative to Help Care Providers Succeed in Medicare Merit-Based Incentive Payment System 26
Oct 10, 2017: Military Health System Beneficiaries to Receive Global Nurse Advice Line Services from Optum 27
Sep 13, 2016: Optum and Quest Diagnostics Partner to Help Make the Health System Work Better for Patients, Physicians, Health Plans and Employers 28
Aug 04, 2016: OptumCare Selects Allscripts to Provide its Physicians a Connected Health IT Platform 29
May 04, 2016: Optum teams with Medecision, TriZetto on New Offering to Streamline States’ Medicaid Management Information Systems 30
Jan 20, 2016: Optum and Availity Partner to Improve Health Insurance Claims Submission Process for the Benefit of Care Professionals, Consumers and Health Plans 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Optum Inc, Medical Equipment, Key Facts 2
Optum Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Optum Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Optum Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Optum Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Optum Inc, Deals By Market, 2011 to YTD 2017 8
Optum Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
MedSynergies Raises US$65 Million In Venture Financing 10
MedSynergies Secures US$25.05 Million In Financing Round 11
OptumCare Enters into Agreement with Allscripts Healthcare 12
MedSynergies Forms Joint Venture with Sentara Healthcare 13
MedSynergies Forms Joint Venture with Catholic Health 14
MedSynergies Forms Joint Venture with Excellence Headquarters 15
MedSynergies Forms Joint Venture with Vanguard Health 16
Optum to Acquire Surgical Care Affiliates 17
Optum to Acquire MedSynergies, Healthcare IT Company 19
Optum Inc, Key Competitors 20
Optum Inc, Key Employees 21
Optum Inc, Subsidiaries 22

★海外企業調査レポート[Optum Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Steelcase Inc. (SCS):企業の財務・戦略的SWOT分析
    Steelcase Inc. (SCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • GlycoMimetics Inc (GLYC):製薬・医療:M&Aディール及び事業提携情報
    Summary GlycoMimetics Inc (GlycoMimetics) is a clinical-stage biotechnology company that research, develops and commercializes small molecule drugs. The company’s products comprise rivipansel (GMI-1070), under phase III clinical trial is an anti-inflammatory compound to treat vaso-occlusive crisis o …
  • Hologic Inc (HOLX)-医療機器分野:企業M&A・提携分析
    Summary Hologic Inc (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of …
  • New Enterprise Associates Inc:企業のM&A・事業提携・投資動向
    New Enterprise Associates Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New Enterprise Associates Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Methaq Takaful Insurance Company:企業の戦略・SWOT・財務情報
    Methaq Takaful Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Methaq Takaful Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • South Jersey Industries, Inc. (SJI):石油・ガス:M&Aディール及び事業提携情報
    Summary South Jersey Industries Inc (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also offer …
  • Altius Minerals Corp:企業の戦略・SWOT・財務情報
    Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report Summary Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AEI Services LLC-エネルギー分野:企業M&A・提携分析
    Summary AEI Services LLC (AEI), formerly Ashmore Energy International, is an energy utility company that owns, develops and operates power generation assets. The company also carries out the natural gas transportation and distribution businesses in emerging markets. Its power generation portfolio co …
  • Sypris Solutions Inc (SYPR):企業の財務・戦略的SWOT分析
    Sypris Solutions Inc (SYPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ESSA Pharma Inc (EPI):企業の財務・戦略的SWOT分析
    Summary Essa Pharma Inc (Essa Pharma) is a drug developer that offers oncology therapeutics. The company develops EPI-506, disrupts androgen receptor transcriptional activity through selectively blocking the N-terminal domain of the AR. It also conducts research on prostate cancer and the androgen r …
  • EnWave Corp (ENW)-製薬・医療分野:企業M&A・提携分析
    Summary EnWave Corp (EnWave) is an advanced technology company that provides industrial-scale dehydration technology for commercial applications in the pharmaceutical and food industries. It designs, constructs, markets and sells microwavevacuum biomaterial and food dehydration machines that use pro …
  • OncoStem Diagnostics Pvt. Ltd:企業の製品パイプライン分析2018
    Summary OncoStem Diagnostics Pvt Ltd (OncoStem) is a provider of clinical trial solutions. The company develops multimaker prognostic and predictive testing enabling detecting and treating patients affected with cancer. It develops various tests in identifying patterns of repetition in cancer. OncoS …
  • CullenFrost Bankers Inc (CFR):企業の財務・戦略的SWOT分析
    CullenFrost Bankers Inc (CFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Triumvira Immunologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Triumvira Immunologics Inc (Triumvira) is a biopharmaceutical company developing engineered T cell therapies for the treatment of multiple cancers. Its proprietary immuno-oncology platform T cell Antigen Coupler (TAC), enables natural T cell receptor to induce a controlled, tumor-specific re …
  • Virbac Corporation:企業の戦略・SWOT・財務分析
    Virbac Corporation - Strategy, SWOT and Corporate Finance Report Summary Virbac Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Orbus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Orbus Therapeutics Inc (Orbus Therapeutics) is a clinical-stage biopharmaceutical company that develops and commercializes drugs for the treatment of anaplastic astrocytoma, a rare kind of cancer afflicting the central nervous system. Eflornithine, a cytostatic agent, indicated for the treat …
  • ROHM Co Ltd (6963):企業の財務・戦略的SWOT分析
    ROHM Co Ltd (6963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Coutts & Co:企業の戦略・SWOT・財務情報
    Coutts & Co - Strategy, SWOT and Corporate Finance Report Summary Coutts & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Zealand Pharma AS (ZEAL):製薬・医療:M&Aディール及び事業提携情報
    Summary Zealand Pharma AS (Zealand) is a biotechnology company that discovers, designs and develops peptide based medicines that targets specialty diseases. The company’s marketed products comprise Lyxumia and Suliqua for the treatment of Type 2 diabetes and others for the treatment of obesity and f …
  • Einstein Noah Restaurant Group, Inc. (Foodservice):企業の戦略・SWOT・財務情報
    Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆